Cell Counting Kit-8 (CCK-8): Sensitive Cell Viability and Cytotoxicity Assay Using WST-8

Executive Summary: The Cell Counting Kit-8 (CCK-8) is a colorimetric assay that quantifies cell viability and proliferation by measuring mitochondrial dehydrogenase-mediated reduction of WST-8 to a water-soluble formazan dye. This method yields a direct, linear correlation between viable cell number and absorbance at 450 nm under standardized conditions (Zhang et al. 2025). The CCK-8 assay is more sensitive and less toxic than MTT, XTT, or WST-1 assays (ApexBio product data). It plays a critical role in cancer and neurodegenerative disease research, where precise quantification of cellular responses is required (Next-Generation Quantitative CCK-8). The assay’s simplicity and compatibility with high-throughput workflows make it a preferred choice for modern translational laboratories.

Biological Rationale

Accurate cell viability measurement is foundational in biomedical research. Many cellular processes—including proliferation, cytotoxicity, and metabolic activity—must be quantified in vitro. Mitochondrial dehydrogenase enzymes, which are active only in living cells, provide a robust biochemical indicator for viability assessment (Zhang et al. 2025). The Cell Counting Kit-8 (CCK-8) leverages this principle using WST-8, a water-soluble tetrazolium salt. Unlike MTT, which forms insoluble formazan, WST-8 yields a water-soluble product, facilitating direct and rapid absorbance measurements. This approach minimizes sample loss and avoids the need for solubilization steps, reducing hands-on time and technical variability (Next-Generation Quantitative CCK-8). In cancer research, precise cell number quantification is essential for evaluating proliferation, apoptosis, and therapeutic efficacy (Zhang et al. 2025).

Mechanism of Action of Cell Counting Kit-8 (CCK-8)

The CCK-8 assay utilizes WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium salt) as its core reagent. In viable eukaryotic cells, intracellular dehydrogenases reduce WST-8 in the presence of electron carriers to produce a yellow-orange, water-soluble formazan dye. The chemical reaction occurs at physiological pH and temperature (37°C, pH 7.2–7.4), and the dye concentration is directly proportional to the number of metabolically active cells (ApexBio). Absorbance is measured at 450 nm using a microplate reader. The reaction does not require cell lysis, eliminating sample destruction and enabling downstream analyses. Compared to MTT/XTT/MTS/WST-1, the CCK-8 dye is more water soluble, reducing artifacts from incomplete dissolution (Next-Generation Quantitative CCK-8).

Evidence & Benchmarks

• CCK-8 demonstrates a linear relationship between absorbance (450 nm) and viable cell number in the range of 500–50,000 cells/well (96-well format, 37°C, 2 h incubation) (Zhang et al. 2025).
• The assay enables detection of cytotoxic effects and proliferation changes in acute myeloid leukemia (AML) cell lines, revealing IRF1 knockdown reduces proliferation and increases apoptosis (Zhang et al. 2025, Figure 3).
• CCK-8 provides higher sensitivity and lower cytotoxicity than MTT, permitting longer incubation and more accurate quantification in hypoxic and sensitive cell models (Rigorous Approaches for Hypoxia).
• The water-soluble formazan allows direct measurement without solubilization, decreasing hands-on time by up to 30% compared to MTT assays (manufacturer data) (ApexBio).
• Validated for use in cancer, neural, and metabolic disease models; supports high-throughput screening and automation (Advanced Applications in Neuroinflammation and Cancer).

Applications, Limits & Misconceptions

The Cell Counting Kit-8 (CCK-8) is routinely used in:

• Cell proliferation assays
• Cytotoxicity and drug sensitivity testing
• Assessment of mitochondrial metabolic activity
• Quantification of cell viability in cancer, neurodegenerative, and metabolic disease models

Its compatibility with both adherent and suspension cells, and adaptability to 96- and 384-well plates, make it valuable in diverse research settings. For detailed mechanistic discussions and next-generation benchmarking, see "Next-Generation Quantitative CCK-8", which this article extends by focusing on AML-specific evidence and high-throughput workflow integration. For a broader translational perspective, "From Mechanism to Medicine" offers further context on how WST-8-based viability assays, especially CCK-8, enable robust cellular metabolic assessments—this article clarifies the direct link between IRF1 modulation and CCK-8 readouts in AML models.

Common Pitfalls or Misconceptions

• CCK-8 does not distinguish between apoptosis and necrosis: It reports total viable cell number, not the specific mode of cell death.
• High background from serum or phenol red: Excess serum or colored media components may increase baseline absorbance; use serum-free or phenol red-free media where possible.
• Interference by reducing agents: Compounds such as ascorbic acid can artificially reduce WST-8, leading to false positives.
• Not suitable for extremely high-density cultures: Above 50,000 cells/well (96-well plate), the assay may saturate and lose linearity.
• Does not directly measure cell death pathways: For mechanistic apoptosis/necrosis discrimination, complementary assays (e.g., Annexin V/PI) are needed.

Workflow Integration & Parameters

Typical CCK-8 protocol steps:

1. Seed cells (500–50,000 per well; 96-well format recommended for AML cells).
2. Allow recovery and treatment as required (e.g., 24–72 h, 37°C, 5% CO₂).
3. Add 10 µL CCK-8 reagent per 100 µL culture medium per well.
4. Incubate at 37°C for 1–4 hours, protected from light.
5. Measure absorbance at 450 nm using a microplate reader.

For optimal reproducibility:

• Use phenol red-free, serum-free media when possible to reduce background.
• Validate linearity for each cell type and density.
• Include blank wells (media + CCK-8, no cells) and positive controls.

The K1018 kit is provided ready-to-use and is stable at 2–8°C for at least 12 months. For further guidance on integrating CCK-8 with metabolic and neurodegenerative disease models, see "Translational Impact Through Precision", which this article updates with AML-relevant workflow optimizations.

Conclusion & Outlook

The Cell Counting Kit-8 (CCK-8) is a validated, sensitive, and user-friendly cell viability and cytotoxicity assay that supports high-throughput and translational research. Its water-soluble formazan chemistry yields reliable, reproducible data across multiple disease models, including AML (Zhang et al. 2025). The assay’s streamlined workflow, minimal toxicity, and adaptability to automation distinguish it from legacy tetrazolium salt-based kits. As cancer and neurodegenerative disease research advances, CCK-8 will remain integral for preclinical screening, mechanism-of-action studies, and therapeutic evaluation. For full specifications and ordering, see the Cell Counting Kit-8 (CCK-8) product page.